Drapkin Kimberlee C
SEC insider (Form 3/4/5 filer). CIK 0001340881. Director at LENZ Therapeutics, Inc. (LENZ) and 3 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in NEWTON, MA.
Companies Drapkin Kimberlee C has filed insider reports for
- LENZ Therapeutics, Inc. (LENZ): Director
- Climb Bio, Inc. (CLYM): Director
- Acumen Pharmaceuticals, Inc. (ABOS): Director
- KINETA, INC./DE (KA): Director
Drapkin Kimberlee C
CIK: 0001340881
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 15, 2026LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
22.1K shares- - Jun 5, 2026CLYM
Climb Bio, Inc.
AwardDirectStock Option (Right to Buy)
40K shares- - Jun 3, 2026ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect35.5K shares- - Jun 30, 2025KANT
KINETA, INC./DE
DispositionDirect13.8K shares- - Jun 25, 2025KANT
KINETA, INC./DE
AwardDirect6K shares- - Jun 23, 2025KANT
KINETA, INC./DE
Tax PaymentDirect4.7K shares at avg. $0.26$1K - Jun 23, 2025KANT
KINETA, INC./DE
ExerciseDirect12.5K shares at avg. $0.61$8K - Jun 11, 2025LENZ
LENZ Therapeutics, Inc.
AwardDirectStock Option (right to buy)
13.5K shares- - Jun 4, 2025ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect12.8K shares- - Jun 4, 2025CLYM
Climb Bio, Inc.
AwardDirectStock Option (Right to Buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 22,100 | - | - | Direct |
| Jun 5, 2026 |  CLYM Climb Bio, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Jun 3, 2026 |  ABOS Acumen Pharmaceuticals, Inc. | Award | 35,500 | - | $0 | Direct |
| Jun 30, 2025 |  KANT KINETA, INC./DE | Disposition | 13,794 | - | - | Direct |
| Jun 25, 2025 | KANT KINETA, INC./DE | Award | 6,000 | - | - | Direct |
| Jun 23, 2025 | KANT KINETA, INC./DE | Tax Payment | 4,706 | $0.26 | $1,224 | Direct |
| Jun 23, 2025 | KANT KINETA, INC./DE | Exercise | 12,500 | $0.61 | $7,638 | Direct |
| Jun 11, 2025 | LENZ LENZ Therapeutics, Inc. | Award Stock Option (right to buy) | 13,500 | - | - | Direct |
| Jun 4, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Award | 12,800 | - | - | Direct |
| Jun 4, 2025 | CLYM Climb Bio, Inc. | Award Stock Option (Right to Buy) | 40,000 | - | - | Direct |
1-10 of 12 transactions